These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16392324)

  • 1. [Strategies in prevention, development and progression of diabetic nephropathy].
    Luño J
    Nefrologia; 2005; 25 Suppl 4():48-56. PubMed ID: 16392324
    [No Abstract]   [Full Text] [Related]  

  • 2. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].
    Luño J; Valderrábano F
    An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851
    [No Abstract]   [Full Text] [Related]  

  • 3. Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring.
    Rossing K
    Dan Med Bull; 2007 May; 54(2):79-98. PubMed ID: 17521525
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diabetic nephropathy: prevention strategies beyond renin-angiotensin system blockade].
    Romero R; Salinas I
    Nefrologia; 2005; 25 Suppl 4():42-7. PubMed ID: 16392323
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antihypertensives and their importance in the initial stages of diabetic nephropathy].
    Krusová D
    Vnitr Lek; 1999 Nov; 45(11):664-9. PubMed ID: 10951859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes could cost you your kidneys, act now!
    Viswanathan V
    J Assoc Physicians India; 2003 Nov; 51():1043-4. PubMed ID: 15260385
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypertension arm of ADVANCE defines extent of renal protection using perindopril/indapamide in type 2 diabetics.
    Cardiovasc J Afr; 2008; 19(4):226. PubMed ID: 18776973
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical studies on chronic diabetic nephropathy and recent data concerning prevention of risks of nephropathy and cardiovascular diseases].
    Esnault V
    Nephrol Ther; 2006 May; 2 Suppl 3():S193-6. PubMed ID: 17370850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal and stroke protection in hypertensive patients at CV risk.
    Cardiovasc J Afr; 2007; 18(5):337, 340. PubMed ID: 17985036
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diabetic nephropathy].
    Morcos M; Zeier M; Schwenger V
    Dtsch Med Wochenschr; 2007 May; 132(19):1039-42. PubMed ID: 17476634
    [No Abstract]   [Full Text] [Related]  

  • 12. New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2 - a potential target for treatment of hypertension and diabetic nephropathy.
    Batlle D; Soler MJ; Wysocki J
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):250-7. PubMed ID: 18408475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Another patient with a natural history of diabetic nephropathy: current situation and means of prevention.
    Heras M; Saiz A; Sánchez R; Fernández-Reyes MJ; Molina A; Rodríguez MA
    Nefrologia; 2011; 31(1):108-10. PubMed ID: 21270923
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypertension and diabetes: role of the renin-angiotensin system.
    Jandeleit-Dahm K; Cooper ME
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):469-90, vii. PubMed ID: 16959581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension and antihypertensive treatment of diabetic nephropathy.
    Ritz E; Dikow R
    Nat Clin Pract Nephrol; 2006 Oct; 2(10):562-7. PubMed ID: 17003835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive strategy based on angiotensin II receptor blockers: a new gateway to reduce risk in hypertension.
    Tocci G; Sciarretta S; Facciolo C; Volpe M
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):767-76. PubMed ID: 17605654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk oriented therapy of hypertension. Lowering blood pressure and risk].
    MMW Fortschr Med; 2007 Nov; 149(46):53. PubMed ID: 18069196
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention of the progression of diabetic nephropathy with antihypertensive treatment].
    Moulin B
    Therapie; 1997; 52(5):459-60. PubMed ID: 9501576
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fixed dose combinations of antihypertensive drugs and management of risk of development nephropathy in type 2 diabetes mellitus].
    Fomin VV
    Kardiologiia; 2012; 52(10):81-5. PubMed ID: 23098355
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal protection in diabetic patients: benefits of a first-line combination of perindopril-indapamide (Preterax).
    Ruilope LM; Segura J
    J Hypertens Suppl; 2006 May; 24(3):S9-12. PubMed ID: 16723864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.